A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

Clinical trial NCT01759576 · COMPLETED

Trial details

NCT number: NCT01759576
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Insufficiency Healthy

Start date: 2008-03-01
Primary completion: 2008-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.